295 related articles for article (PubMed ID: 12815694)
1. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
[TBL] [Abstract][Full Text] [Related]
2. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
4. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
[TBL] [Abstract][Full Text] [Related]
5. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
Sijens PE; Mostert JP; Oudkerk M; De Keyser J
Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
[TBL] [Abstract][Full Text] [Related]
6. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
[TBL] [Abstract][Full Text] [Related]
7. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
Stromillo ML; Giorgio A; Rossi F; Battaglini M; Hakiki B; Malentacchi G; Santangelo M; Gasperini C; Bartolozzi ML; Portaccio E; Amato MP; De Stefano N
Neurology; 2013 Jun; 80(23):2090-4. PubMed ID: 23635962
[TBL] [Abstract][Full Text] [Related]
8. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
9. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
Kirov II; Tal A; Babb JS; Herbert J; Gonen O
Neurology; 2013 Jan; 80(1):39-46. PubMed ID: 23175732
[TBL] [Abstract][Full Text] [Related]
10. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
[TBL] [Abstract][Full Text] [Related]
11. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter.
Vrenken H; Barkhof F; Uitdehaag BM; Castelijns JA; Polman CH; Pouwels PJ
Magn Reson Med; 2005 Feb; 53(2):256-66. PubMed ID: 15678547
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients.
Siger-Zajdel M; Selmaj K
Eur J Neurol; 2006 Mar; 13(3):296-8. PubMed ID: 16618349
[TBL] [Abstract][Full Text] [Related]
13. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
14. 3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.
Pelletier D; Nelson SJ; Grenier D; Lu Y; Genain C; Goodkin DE
Magn Reson Imaging; 2002 Oct; 20(8):599-606. PubMed ID: 12467867
[TBL] [Abstract][Full Text] [Related]
15. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
Oh J; Pelletier D; Nelson SJ
Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
[TBL] [Abstract][Full Text] [Related]
16. [The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
Szafirska M; Urbanik A; Róg T
Przegl Lek; 2013; 70(5):328-34. PubMed ID: 23944105
[TBL] [Abstract][Full Text] [Related]
17. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W
PLoS One; 2010 Jul; 5(7):e11625. PubMed ID: 20652023
[TBL] [Abstract][Full Text] [Related]
18. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
[TBL] [Abstract][Full Text] [Related]
19. Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Hannoun S; Bagory M; Durand-Dubief F; Ibarrola D; Comte JC; Confavreux C; Cotton F; Sappey-Marinier D
PLoS One; 2012; 7(3):e32525. PubMed ID: 22479330
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
